GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)
Pill imprint GG 367 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)
- 20 mg / 25 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|33358-0050||Core Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Benazepril hydrochloride and hydrochlorothiazide is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...